Credit Suisse Starts Sarepta Therapeutic (SRPT) at Outperform

October 18, 2016 6:34 AM EDT Send to a Friend
Credit Suisse initiates coverage on Sarepta Therapeutic (NASDAQ: SRPT) with a Outperform rating and a price target of $68.00.Analyst Alethia ...

To continue reading this article and more like it please sign-in or join today (FREE!)

Member Login